positive regulation of mitotic cell cycle DNA replication


positive regulation of methane biosynthetic process from carbon monoxide

biolink:BiologicalProcess biolink:Occurrent biolink:OntologyClass biolink:BiologicalProcessOrActivity biolink:BiologicalEntity biolink:NamedThing biolink:Entity biolink:PhysicalEssenceOrOccurrent


positive regulation of toluene catabolic process


negative regulation of cobalamin metabolic process


regulation of acetylcholine metabolic process


positive regulation of nucleobase-containing compound metabolic process


positive regulation of transcription by RNA polymerase II


regulation of camalexin biosynthetic process


negative regulation of syringal lignin biosynthetic process


positive regulation of ethanol catabolic process by positive regulation of transcription from RNA polymerase II promoter


positive regulation of termination of DNA-templated transcription


positive regulation of nuclear-transcribed mRNA catabolic process, meiosis-specific transcripts


regulation of (+)-kotanin biosynthetic process


negative regulation of phosphatidic acid biosynthetic process


positive regulation of transcription from RNA polymerase II promoter in response to cobalt ion


negative regulation of toluene catabolic process


negative regulation of hh target transcription factor activity


regulation of mitotic DNA replication initiation from early origin


regulation of acetylcholine biosynthetic process


regulation of iron-sulfur cluster assembly


positive regulation of single stranded viral RNA replication via double stranded DNA intermediate


positive regulation of RNA biosynthetic process


regulation of transcription from RNA polymerase II promoter in response to iron ion starvation


regulation of phosphatidylcholine metabolic process


regulation of mitochondrial ATP synthesis coupled proton transport


positive regulation of D-erythro-sphingosine kinase activity


positive regulation of DNA-templated transcription


regulation of diorcinol biosynthetic process


regulation of diacylglycerol biosynthetic process


activation of reciprocal meiotic recombination


regulation of methane biosynthetic process from methanethiol


negative regulation of juvenile hormone catabolic process


nitrogen catabolite activation of transcription from RNA polymerase II promoter


positive regulation of brassinosteroid biosynthetic process


positive regulation of mannan catabolic process


positive regulation of diacylglycerol biosynthetic process


negative regulation of xylan catabolic process


positive regulation of glucuronoarabinoxylan catabolic process


regulation of cell wall polysaccharide catabolic process


positive regulation of transcription from RNA polymerase II promoter in response to ethanol


positive regulation of RNA metabolic process


positive regulation of transposition, DNA-mediated


positive regulation of nucleic acid-templated transcription


negative regulation of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process


regulation of thiamine diphosphate biosynthetic process


regulation of polynucleotide 3'-phosphatase activity


positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled


regulation of cell wall (1->3)-alpha-glucan metabolic process


regulation of fungal-type cell wall (1->3)-alpha-glucan biosynthetic process


regulation of double-strand break repair via single-strand annealing, removal of nonhomologous ends


regulation of single-strand break repair via homologous recombination


positive regulation of methane biosynthetic process from methylamine


positive regulation of DNA primase activity


positive regulation of iron-sulfur-molybdenum cofactor assembly


regulation of poly(A)-specific ribonuclease activity


negative regulation of hydrogen sulfide biosynthetic process


negative regulation of acetylcholine metabolic process


regulation of inositol-polyphosphate 5-phosphatase activity


regulation of DNA replication termination


regulation of lactose biosynthetic process


positive regulation of hydrogen peroxide catabolic process


positive regulation of endoribonuclease activity


regulation of xyloglucan metabolic process


regulation of coenzyme F420-dependent bicyclic nitroimidazole catabolic process


induction by virus of host reticulophagy


positive regulation of meiotic DNA double-strand break formation involved in reciprocal meiotic recombination


regulation of plant-type cell wall cellulose catabolic process


positive regulation of 'de novo' NAD biosynthetic process from tryptophan


positive regulation of transcription from RNA polymerase II promoter in response to iron


regulation of dolichol biosynthetic process


regulation of pentose catabolic process to ethanol


negative regulation of electron transfer activity


negative regulation of sulfur amino acid metabolic process


regulation of glucose-6-phosphatase activity


regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity


positive regulation of DNA strand resection involved in replication fork processing


positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA


regulation of trehalose metabolic process


positive regulation of cellulose catabolic process


positive regulation of mitochondrial DNA replication


regulation of thiamine biosynthetic process


positive regulation of phosphatidate phosphatase activity


negative regulation of estrogen biosynthetic process


positive regulation of termination of RNA polymerase II transcription


positive regulation of mRNA cis splicing, via spliceosome


regulation of type IV site-specific deoxyribonuclease activity


negative regulation of cell wall polysaccharide catabolic process


negative regulation of UDP-N-acetylglucosamine biosynthetic process


negative regulation of indoleacetic acid biosynthetic process via tryptophan


positive regulation of telomere maintenance via semi-conservative replication


regulation of cardiolipin metabolic process


positive regulation of mRNA alternative polyadenylation


positive regulation of error-prone translesion synthesis


positive regulation of sulfate assimilation


regulation of UDP-glucose catabolic process


positive regulation of capsule polysaccharide biosynthetic process


regulation of indoleacetic acid biosynthetic process via tryptophan


positive regulation of exoribonuclease activity


induction of phytoalexin biosynthetic process


regulation of apurinic/apyrimidinic endodeoxyribonuclease activity


positive regulation of xyloglucan catabolic process


regulation of mitochondrial mRNA catabolic process


regulation of fumagillin biosynthetic process


positive regulation of arabinoxylan-containing compound catabolic process


regulation of demethylkotanin biosynthetic process


regulation of inositol biosynthetic process


positive regulation of ent-pimara-8(14),15-diene biosynthetic process


positive regulation of camalexin biosynthetic process


positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity


negative regulation of ent-pimara-8(14),15-diene biosynthetic process


negative regulation of sulfur metabolic process


negative regulation of removal of superoxide radicals


negative regulation of phosphatidylserine metabolic process


regulation of photosynthesis, light reaction


regulation of 1-phosphatidylinositol 4-kinase activity


regulation of transcription-coupled nucleotide-excision repair


positive regulation of polynucleotide 3'-phosphatase activity


negative regulation of cellular biosynthetic process


regulation of meiotic DNA double-strand break formation involved in reciprocal meiotic recombination


regulation of glycolytic fermentation to ethanol


positive regulation of phosphate metabolic process


negative regulation of sarcinapterin metabolic process


regulation of ascospore wall beta-glucan biosynthetic process


regulation of fructose 1,6-bisphosphate 1-phosphatase activity


negative regulation of photosynthesis, light reaction


positive regulation of DNA recombination at telomere


regulation of violaceol II biosynthetic process


negative regulation of xyloglucan catabolic process


regulation of membrane lipid metabolic process


regulation of diacylglycerol kinase activity


negative regulation of amylopectin catabolic process


positive regulation of tRNA catabolic process


negative regulation of (1->3)-beta-D-glucan biosynthetic process


negative regulation of thyroid hormone generation


negative regulation of starch metabolic process


regulation of methane biosynthetic process from methylamine


regulation of transcription from RNA polymerase II promoter in response to biotin starvation


regulation of syringal lignin catabolic process


regulation of polyamine biosynthetic process


positive regulation of transposon integration


negative regulation of isoprenoid metabolic process


positive regulation of transcription from RNA polymerase II promoter in response to cold


negative regulation of sinapate ester biosynthetic process


regulation of plant-type cell wall cellulose biosynthetic process


regulation of replication fork arrest at rDNA repeats


positive regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization


negative regulation of xyloglucan metabolic process


negative regulation of phosphorus utilization


regulation of cellular biosynthetic process


regulation of syringal lignin biosynthetic process


positive regulation of isoprenoid metabolic process


negative regulation of mitochondrial ATP synthesis coupled proton transport


positive regulation of thiamine biosynthetic process


regulation of 1-phosphatidylinositol-3-kinase activity


positive regulation of transcription from RNA polymerase II promoter in response to maltose


negative regulation melanotic encapsulation of foreign target


spatial regulation of meiotic DNA double-strand break formation involved in reciprocal meiotic recombination


positive regulation of phosphorus metabolic process


regulation of phosphatidate phosphatase activity


positive regulation of estrogen biosynthetic process


negative regulation of methane biosynthetic process from methanethiol


positive regulation of melanization defense response


negative regulation of xylose catabolic process to ethanol


positive regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay


negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity


regulation of termination of RNA polymerase II transcription


negative regulation of inositol biosynthetic process


positive regulation of transcription from RNA polymerase II promoter in response to heat stress


positive regulation of juvenile hormone metabolic process


regulation of mRNA stability involved in response to stress


negative regulation of phosphatidylcholine catabolic process


regulation of brassinosteroid biosynthetic process


positive regulation of hydrogen sulfide biosynthetic process


positive regulation of transcription from RNA polymerase II promoter in response to methylglyoxal


negative regulation of methane biosynthetic process from dimethyl sulfide


regulation of alpha-glucan biosynthetic process


negative regulation of iron-sulfur-molybdenum cofactor assembly


positive regulation of inositol-polyphosphate 5-phosphatase activity


positive regulation of glycolytic fermentation to ethanol


positive regulation of pyrimidine nucleotide biosynthetic process


positive regulation of DNA ligase activity


negative regulation of 1-phosphatidylinositol 4-kinase activity


negative regulation of ergosterol biosynthetic process


positive regulation of phytol biosynthetic process


regulation of mRNA alternative polyadenylation


positive regulation of mitotic recombination-dependent replication fork processing


regulation of hydrogen sulfide biosynthetic process


regulation of exodeoxyribonuclease activity


regulation of cellulose biosynthetic process


regulation of mRNA cis splicing, via spliceosome


regulation of (1->3)-beta-D-glucan biosynthetic process


positive regulation of DNA amplification


regulation of electron transfer activity


negative regulation of cellulose biosynthetic process


protection of DNA demethylation of female pronucleus


positive regulation of auxin biosynthetic process


regulation of DNA double-strand break processing


positive regulation of reverse transcription


positive regulation of amylopectin catabolic process


positive regulation of auxin metabolic process


positive regulation of transcription from RNA polymerase II promoter in response to glucose starvation


regulation of 3'-UTR-mediated mRNA stabilization


regulation of cellular macromolecule biosynthetic process


regulation of cellobiose catabolic process


regulation of juvenile hormone biosynthetic process


negative regulation of brassinosteroid biosynthetic process


regulation of phenylpropanoid metabolic process


regulation of transcription from RNA polymerase II promoter by a nonfermentable carbon source


regulation of capsule polysaccharide biosynthetic process


positive regulation of transcription from RNA polymerase II promoter in response to reactive oxygen species


negative regulation of tatiopterin biosynthetic process


negative regulation of spermidine biosynthetic process


regulation of transcription from RNA polymerase II promoter in response to DNA damage


negative regulation of cordyol C biosynthetic process


positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance


regulation of estrogen biosynthetic process


positive regulation of transcription by galactose


negative regulation of coenzyme F420-dependent bicyclic nitroimidazole catabolic process


positive regulation of cellobiose metabolic process


positive regulation of isopentenyl diphosphate biosynthetic process, mevalonate pathway


hereditary painful callosities

biolink:Disease biolink:DiseaseOrPhenotypicFeature biolink:ThingWithTaxon biolink:BiologicalEntity biolink:NamedThing biolink:Entity


X-linked sideroblastic anemia with ataxia


4-ketotorulene 3-hydroxylase activity

biolink:MolecularActivity biolink:Occurrent biolink:OntologyClass biolink:BiologicalProcessOrActivity biolink:BiologicalEntity biolink:NamedThing biolink:Entity biolink:PhysicalEssenceOrOccurrent


Undifferentiated Juvenile Idiopathic Arthritis


diacetyl reductase ((S)-acetoin forming) activity


(+)-abscisic acid 8'-hydroxylase activity


Stage IVB Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8


Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy by AJCC v8 Stage


Stage IVA Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8


Stage IVC Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8


Stage III Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8


Recurrent Metastatic Merkel Cell Carcinoma


Recurrent Metastatic Digestive System Carcinoma


Recurrent Metastatic Malignant Neoplasm in the Leptomeninges


Recurrent Metastatic Skin Squamous Cell Carcinoma


areolar gland

biolink:GrossAnatomicalStructure biolink:AnatomicalEntity biolink:ThingWithTaxon biolink:PhysicalEssence biolink:OrganismalEntity biolink:BiologicalEntity biolink:NamedThing biolink:Entity biolink:PhysicalEssenceOrOccurrent


modulation by symbiont of host B-cell mediated immune response


suppression by symbiont of host B-cell mediated immune response


Germinative Follicular Epithelium

biolink:AnatomicalEntity biolink:ThingWithTaxon biolink:PhysicalEssence biolink:OrganismalEntity biolink:BiologicalEntity biolink:NamedThing biolink:Entity biolink:PhysicalEssenceOrOccurrent


Mitochondrially Inherited Nonsyndromic Sensorineural Deafness


Deafness due to Connexin 26 Gene Anomaly


autosomal recessive nonsyndromic hearing loss 1A


autosomal recessive nonsyndromic hearing loss 49


autosomal dominant nonsyndromic hearing loss 36


autosomal recessive nonsyndromic hearing loss 36


autosomal recessive nonsyndromic hearing loss 28


autosomal recessive nonsyndromic hearing loss 39


autosomal dominant nonsyndromic hearing loss 41


X-linked hereditary sensory and autonomic neuropathy with hearing loss


severe intellectual disability-progressive spastic diplegia syndrome


Testicular Mixed Choriocarcinoma and Teratoma


positive regulation of protein localization to adherens junction


C-19 gibberellin 2-beta-dioxygenase activity


C-20 gibberellin 2-beta-dioxygenase activity


glutamate catabolic process via L-citramalate


hyperphosphatasia with intellectual disability syndrome 2


External Prosthetic Device Pain

biolink:PhenotypicFeature biolink:DiseaseOrPhenotypicFeature biolink:ThingWithTaxon biolink:BiologicalEntity biolink:NamedThing biolink:Entity


Malignant nasopharyngeal neoplasm recurrent


negative regulation of RNA import into nucleus


follicular dendritic cell sarcoma of mediastinum


negative regulation of store-operated calcium channel activity


negative regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity


negative regulation of high voltage-gated calcium channel activity


regulation of light-activated voltage-gated calcium channel activity


Pancreatic Mucinous-Cystic Neoplasm, High Grade


peptidyl-arginine dihydroxylation to peptidyl-3,4-dihydroxy-L-arginine


peptidyl-arginine hydroxylation to peptidyl-4-hydroxy-L-arginine


positive regulation of filamentous growth of a population of unicellular organisms in response to chemical stimulus


Parenteral Nutrition - Associated Cholestasis


amyloidosis, primary localized cutaneous, 1


familial primary localized cutaneous amyloidosis


amyloidosis, primary localized cutaneous, 3


amyloidosis, primary localized cutaneous, 2


negative regulation of mediator complex assembly


Stage IB Fallopian Tube Cancer AJCC v6 and v7


negative regulation of cardiac muscle cell myoblast differentiation


positive regulation of branching morphogenesis of a nerve


negative regulation of vascular wound healing


negative regulation of cell adhesion involved in sprouting angiogenesis


follicular atrophoderma-basal cell carcinoma


feminization of hermaphroditic germ-line


masculinization of hermaphroditic germ-line


hermaphrodite germ-line sex determination


macula of saccule of membranous labyrinth


macula of utricle of membranous labyrinth


sick sinus syndrome 2, autosomal dominant


negative regulation of toll-like receptor 1 signaling pathway


congenital narrowing of cervical spinal canal


microtubule nucleation by spindle pole body


mitotic spindle-templated microtubule nucleation


adaptive immune memory response involving T cells and B cells


alcohol dehydrogenase activity, iron-dependent


alcohol dehydrogenase activity, metal ion-independent


regulation of timing of meristematic phase transition


regulation of timing of transition from vegetative to reproductive phase


histone H3K27 trimethyltransferase activity


histone H3K27 monomethyltransferase activity


histone H3K27 dimethyltransferase activity


non-professional antigen presenting cell antigen processing and presentation


Refractory Vaginal Squamous Cell Carcinoma


negative regulation of muscle cell chemotaxis toward tendon cell


regulation of muscle cell chemotaxis toward tendon cell


positive regulation of skeletal muscle satellite cell proliferation


positive regulation of growth factor dependent skeletal muscle satellite cell proliferation


zinc D-Ala-D-Ala carboxypeptidase activity


positive regulation of cellodextrin catabolic process


positive regulation of cellodextrin metabolic process


aminoglycoside antibiotic biosynthetic process


2:1 Atrioventricular Block by ECG Finding


Myeloblasts 5-19 Percent of Peripheral Blood White Cells


Myeloblasts 10-19 Percent of Peripheral Blood White Cells


decanoate-[HmqF protein] ligase activity


butyryl-CoA biosynthetic process from acetyl-CoA


protein-N(PI)-phosphohistidine-mannose phosphotransferase system transporter activity


myenteric nerve plexus of small intestine


bidirectional double-stranded viral DNA replication


regulation of anterograde dense core granule transport


positive regulation of early endosome to recycling endosome transport


regulation of dense core granule transport


positive regulation of retrograde transport, endosome to Golgi


negative regulation of retrograde dense core granule transport


negative regulation of retrograde transport, endosome to Golgi


negative regulation of anterograde dense core granule transport


regulation of retrograde dense core granule transport


regulation of retrograde transport, endosome to Golgi


positive regulation of dense core granule transport


negative regulation of dense core granule transport


positive regulation of retrograde dense core granule transport


positive regulation of anterograde dense core granule transport


2-hydroxy-3-methyl-branched 2,3,4-saturated fatty acyl-CoA lyase activity


epicardium-derived cardiac fibroblast cell differentiation


compound eye photoreceptor fate commitment


ocellus photoreceptor cell fate commitment


peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity


peptidyl-tyrosine dephosphorylation involved in activation of protein kinase activity


Prostate Stromal Proliferation of Uncertain Malignant Potential


Secondary malignant neoplasm of supraclavicular lymph nodes


metastatic malignant neoplasm in the lymph nodes


Metastatic Malignant Neoplasm in the Regional Lymph Nodes


Breast Carcinoma Metastatic in the Lymph Nodes


Secondary malignant neoplasm of mediastinal lymph nodes


Prostate Carcinoma Metastatic in the Lymph Nodes


Metastatic Squamous Cell Carcinoma in the Cervical Lymph Nodes


Dextro-Transposition of the Great Vessels with Intact Ventricular Septum


positive regulation of muscle hyperplasia


Central Nervous System Teratoma with Malignant Transformation


Sellar Teratoma with Malignant Transformation


Steroid Resistant Gastrointestinal Tract Acute Graft Versus Host Disease


positive regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis


positive regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis


positive regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis


regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis


positive regulation of somatic stem cell population maintenance


negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis


positive regulation of single-species biofilm formation on inanimate substrate


ACTH-independent macronodular adrenal hyperplasia 1


Cushing syndrome due to macronodular adrenal hyperplasia


ACTH-independent macronodular adrenal hyperplasia 2


intracellular sodium activated potassium channel activity


mechanosensitived potassium channel activity


G-protein gated potassium channel activity


mitochondrial ATP-gated potassium channel activity


voltage-gated potassium channel activity involved in SA node cell action potential repolarization


voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization


voltage-gated potassium channel activity involved in SA node cell action potential depolarization


Intermediate conductance calcium-activated potassium channel activity


open rectifier potassium channel activity


voltage-gated potassium channel activity involved in Purkinje myocyte action potential repolarization


G-protein gated potassium channel activity involved in regulation of postsynaptic membrane potential


voltage-gated potassium channel activity involved in AV node cell action potential repolarization


aldehyde dehydrogenase (quinone) activity


microphthalmia, isolated, with coloboma 4


Stage IV Colorectal Neuroendocrine Tumor AJCC v8


Stage IV Colon Neuroendocrine Tumor AJCC v8


Stage IV Rectal Neuroendocrine Tumor AJCC v8


Pyogenic granuloma of skin and subcutaneous tissue


metastatic malignant neoplasm in the colon


metastatic malignant neoplasm in the eye


Stage II Appendix Neuroendocrine Tumor AJCC v7


Advanced Vaginal Adenosquamous Carcinoma


Advanced Cervical Squamous Cell Carcinoma


Advanced Vaginal Squamous Cell Carcinoma


Advanced Renal Pelvis and Ureter Urothelial Carcinoma


Advanced Microsatellite Stable Ovarian Carcinoma


Advanced Microsatellite Stable Endometrial Carcinoma


Advanced Vaginal Squamous Cell Carcinoma, Not Otherwise Specified


Advanced Cervical Adenosquamous Carcinoma


hereditary continuous muscle fiber activity


posterior lateral line system development


basal ganglia calcification, idiopathic, 1


Recurrent Grade II Lymphomatoid Granulomatosis


Recurrent Grade I Lymphomatoid Granulomatosis


Recurrent Childhood Lymphomatoid Granulomatosis


Extraocular Cutaneous Sebaceous Carcinoma


superficial anterior cervical lymph node


pyruvate biosynthetic process from acetate


para-aminobenzoic acid biosynthetic process


(R)-mandelate catabolic process to benzoate


(R)-2-hydroxy-alpha-linolenic acid biosynthetic process


indoleacetic acid biosynthetic process via tryptophan


D(-)-lactate biosynthetic process from pyruvate


regulation of fever generation by prostaglandin biosynthetic process


cyclic 2,3-bisphospho-D-glycerate biosynthetic process


D-lactate biosynthetic process from methylglyoxal via (R)-lactaldehyde


butyryl-CoA catabolic process to butyrate


tryptophan-independent indoleacetic acid biosynthetic process


methionine catabolic process to 3-methylthiopropanoate


acetate biosynthetic process from carbon monoxide


protein deglycation, methylglyoxal removal


2-dehydro-3-deoxy-D-gluconic acid biosynthetic process


L(+)-lactate biosynthetic process from pyruvate


positive regulation of fever generation by prostaglandin biosynthetic process


chronic lymphoproliferative disorder of NK-cells


UDP-N-acetylgalactosamine transmembrane transporter activity


autosomal recessive early-onset Parkinson disease 23


autosomal recessive juvenile Parkinson disease 2


autosomal recessive early-onset Parkinson disease 7


Parkinson disease 22, autosomal dominant


autosomal recessive early-onset Parkinson disease 6


autosomal recessive Parkinson disease 14


Congenital insufficiency of pulmonary valve


negative regulation of sorocarp stalk cell differentiation


positive regulation of sorocarp stalk cell differentiation


negative regulation of transposition, RNA-mediated


Triple-Class Refractory Plasma Cell Myeloma


negative regulation of cholangiocyte proliferation


regulation of cholangiocyte proliferation


negative regulation of nucleoside transport


negative regulation of adenosine transport


negative regulation of purine nucleoside transport


negative regulation of inosine transport


negative regulation of octopamine signaling pathway involved in response to food


negative regulation of octopamine signaling pathway


positive regulation of actin filament polymerization involved in sperm capacitation


detection of light stimulus involved in magnetoreception


Blasts 9 Percent or Less of Peripheral Blood White Cells


Renal Tubular Acidosis Associated With Deafness


Refractory Chronic Myelomonocytic Leukemia


myasthenic syndrome, congenital, 1B, fast-channel


autosomal recessive congenital ichthyosis 3


autosomal recessive congenital ichthyosis 4B


presynaptic congenital myasthenic syndrome


congenital myasthenic syndrome with tubular aggregates


ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3


blepharophimosis-epicanthus inversus-ptosis due to copy number variations


ptosis-upper ocular movement limitation-absence of lacrimal punctum syndrome


camptodactyly, myopia, and fibrosis of the medial rectus muscle of eye


blepharophimosis-epicanthus inversus-ptosis due to 3q23 rearrangement syndrome


myasthenic syndrome, congenital, 24, presynaptic


fibrosis of extraocular muscles, congenital, with synergistic divergence


metopic ridging-ptosis-facial dysmorphism syndrome


myasthenic syndrome, congenital, 7B, presynaptic, autosomal recessive


myasthenia, congenital, refractory to acetylcholinesterase inhibitors


keratosis follicularis spinulosa decalvans


congenital fibrosis of extraocular muscles type 1


blepharophimosis, ptosis, and epicanthus inversus syndrome


myasthenic syndrome, congenital, 25, presynaptic


fibrosis of extraocular muscles, congenital, 2


fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement


blepharophimosis-ptosis-epicanthus inversus syndrome type 2


congenital myasthenic syndromes with glycosylation defect


atrioventricular defect-blepharophimosis-radial and anal defect syndrome


ichthyosis, lamellar, autosomal dominant


fibrosis of extraocular muscles, congenital, 3c


autosomal recessive congenital ichthyosis 8


autosomal recessive congenital ichthyosis 6


blepharophimosis-ptosis-epicanthus inversus syndrome type 1


autosomal recessive congenital ichthyosis 5


postsynaptic congenital myasthenic syndrome


fibrosis of extraocular muscles, congenital, 5


keratosis follicularis spinulosa decalvans, autosomal dominant


blepharophimosis-epicanthus inversus-ptosis due to a point mutation syndrome


autosomal recessive congenital ichthyosis 4A


keratosis follicularis spinulosa decalvans, X-linked


maternally-inherited progressive external ophthalmoplegia


ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 1


combined immunodeficiency due to DOCK8 deficiency


caffeoyl CoA:S-adenosyl-L-methionine O-methyltransferase activity


acrodysostosis 1 with or without hormone resistance


acrodysostosis 2 with or without hormone resistance


positive regulation of branchiomeric skeletal muscle development


positive regulation of extraocular skeletal muscle development


positive regulation of somitomeric trunk muscle development


Acute Megakaryoblastic Leukemia with NUP98-KDM5A


RNA polymerase II C-terminal domain phosphoserine binding


RNA polymerase II CTD heptapeptide repeat peptidyl-prolyl isomerase activity


RNA polymerase II C-terminal domain P3 isomerase activity


RNA polymerase II C-terminal domain P6 isomerase activity


NADH dehydrogenase complex (plastoquinone) assembly


FAD-dependent H3K4me/H3K4me3 demethylase activity


histone H3K4me/H3K4me2/H3K4me3 demethylase activity


positive regulation of NAD+ ADP-ribosyltransferase activity


negative regulation of NAD+ ADP-ribosyltransferase activity


facioscapulohumeral muscular dystrophy 1


Stage I Rectal Neuroendocrine Tumor AJCC v8


intramolecular proline-rich ligand binding


receptor tyrosine kinase-like orphan receptor binding


glutamate-cysteine ligase catalytic subunit binding


type 4 proteinase activated receptor binding


type 2 metabotropic GABA receptor binding


RNA polymerase II-specific DNA-binding transcription factor binding


TFIIE-class transcription factor complex binding


MHC class Ib protein binding, via antigen binding groove


G protein-coupled histamine receptor binding


type B gastrin/cholecystokinin receptor binding


type 1 cysteinyl leukotriene receptor binding


G protein-coupled acetylcholine receptor binding


TFIIA-class transcription factor complex binding


type 4 metabotropic glutamate receptor binding


MHC class I protein binding, via antigen binding groove


Edg-6 sphingosine 1-phosphate receptor binding


plastid single-subunit type RNA polymerase binding


TFIIIB-class transcription factor complex binding


type 2 metabotropic glutamate receptor binding


prolactin-releasing peptide receptor binding


EP3 subtype prostaglandin E2 receptor binding


Edg-4 lysophosphatidic acid receptor binding


mitochondrial single-subunit type RNA polymerase binding


RNA polymerase II complex recruiting activity


cadherin binding involved in cell-cell adhesion


K6-linked polyubiquitin modification-dependent protein binding


type 1 metabotropic GABA receptor binding


melanin-concentrating hormone receptor binding


Edg-1 sphingosine 1-phosphate receptor binding


K11-linked polyubiquitin modification-dependent protein binding


gonadotropin-releasing hormone receptor binding


platelet activating factor receptor binding


nuclear mineralocorticoid receptor binding


macrophage migration inhibitory factor binding


granulocyte macrophage colony-stimulating factor complex binding


cell adhesive protein binding involved in Purkinje myocyte-ventricular cardiac muscle cell communication


bacterial-type RNA polymerase core enzyme binding


high molecular weight B cell growth factor receptor binding


TFIIH-class transcription factor complex binding


RNA polymerase II C-terminal domain binding


EP2 subtype prostaglandin E2 receptor binding


MHC class II protein binding, via lateral surface


type 6 metabotropic glutamate receptor binding


type 7 metabotropic glutamate receptor binding


single-subunit type RNA polymerase binding


TFIIB-class transcription factor binding


Edg-7 lysophosphatidic acid receptor binding


peroxisome membrane class-2 targeting sequence binding


TFIIIA-class transcription factor binding


ADP-D-ribose modification-dependent protein binding


EP4 subtype prostaglandin E2 receptor binding


calcium-dependent outer dynein arm binding


peroxisome matrix targeting signal-2 binding


glial cell-derived neurotrophic factor receptor binding


intercellular adhesion molecule-3 receptor binding


cell adhesive protein binding involved in AV node cell-bundle of His cell communication


DNA-binding transcription factor binding


pituitary adenylate cyclase-activating polypeptide receptor binding


gastric inhibitory polypeptide receptor binding


laminin binding involved in cell-matrix adhesion


orexigenic neuropeptide QRFP receptor binding


poly-ADP-D-ribose modification-dependent protein binding


type 1 melanin-concentrating hormone receptor binding


thyrotropin-releasing hormone receptor binding


MHC class I protein binding, via lateral surface


type 2 vasoactive intestinal polypeptide receptor binding


type 5 metabotropic glutamate receptor binding


cell adhesive protein binding involved in SA cardiac muscle cell-atrial cardiac muscle cell communication


imaginal disc growth factor receptor binding


ubiquitin modification-dependent histone binding


C5a anaphylatoxin chemotactic receptor binding


Edg-3 sphingosine 1-phosphate receptor binding


TFIIF-class transcription factor complex binding


type 8 metabotropic glutamate receptor binding


eukaryotic initiation factor eIF2 binding


type 3 proteinase activated receptor binding


growth hormone-releasing hormone receptor binding


C5L2 anaphylatoxin chemotactic receptor binding


type 2 melanin-concentrating hormone receptor binding


plastid PEP RNA polymerase core enzyme binding


high molecular weight kininogen receptor binding


gastrin-releasing peptide receptor binding


type 1 parathyroid hormone receptor binding


lutropin-choriogonadotropic hormone receptor binding


type 1 proteinase activated receptor binding


cell adhesive protein binding involved in atrial cardiac muscle cell-AV node cell communication


bacterial-type RNA polymerase holo enzyme binding


general transcription initiation factor binding


type 1 vasoactive intestinal polypeptide receptor binding


peroxisome membrane targeting sequence binding


integrin binding involved in cell-matrix adhesion


vasoactive intestinal polypeptide receptor binding


amino-terminal vacuolar sorting propeptide binding


type 2 proteinase activated receptor binding


type 2 cysteinyl leukotriene receptor binding


ubiquitination-like modification-dependent protein binding


Edg-5 sphingosine 1-phosphate receptor binding


G protein-coupled nucleotide receptor binding


mono-ADP-D-ribose modification-dependent protein binding


protein insertion into ER membrane by stop-transfer membrane-anchor sequence


negative regulation of cellular response to amino acid starvation


chronic lymphocytic leukemia/small lymphocytic lymphoma


intrapelvic lymph node leukemic reticuloendotheliosis


pregerminal center chronic lymphocytic leukemia/small lymphocytic lymphoma


chronic lymphocytic leukemia/small lymphocytic lymphoma with immunoglobulin heavy chain variable-region gene somatic hypermutation


Breast Classic Lobular Carcinoma In Situ Type B


Prognostic Stage IIIA Breast Cancer AJCC v8


Breast Ductal Carcinoma In Situ and Invasive Lobular Carcinoma


Intraductal Micropapillary Breast Carcinoma


Solid papillary carcinoma in situ of breast


Invasive Breast Lobular Carcinoma, Solid Variant


Metastatic Triple-Negative Breast Carcinoma


Invasive Breast Lobular Carcinoma with Predominant In Situ Component


Invasive Breast Lobular Carcinoma, Alveolar Variant


High Grade Ductal Breast Carcinoma In Situ


Breast Carcinoma Metastatic in the Liver


Unresectable HER2-Negative Breast Carcinoma


Squamous Cell Carcinoma In Situ of the Nipple


Prognostic Stage 0 Breast Cancer AJCC v8


Refractory HER2-Positive Breast Carcinoma


Invasive Breast Solid Papillary Carcinoma


adenocarcinoma of breast with neuroendocrine differentiation


Metastatic Breast Inflammatory Carcinoma


Metastatic Breast Neuroendocrine Tumor G1


Breast Classic Lobular Carcinoma In Situ


Metastatic HER2-Negative Breast Carcinoma


Recurrent HER2-Positive Breast Carcinoma


Hormone Receptor-Positive Breast Carcinoma


Refractory Hormone Receptor-Positive Breast Carcinoma


Metastatic Breast Neuroendocrine Neoplasm


Inflammatory carcinoma of breast stage III


High Grade Breast Mucoepidermoid Carcinoma


Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma


Breast Cancer by AJCC v8 Prognostic Stage


Locally Advanced HER2-Negative Breast Carcinoma


Prognostic Stage IIB Breast Cancer AJCC v8


Low Grade Breast Adenosquamous Carcinoma


Refractory Triple-Negative Breast Carcinoma


Noninfiltrating intraductal papillary adenocarcinoma (morphologic abnormality)


Metastatic Breast Signet Ring Cell Carcinoma


Inflammatory carcinoma of breast recurrent


Breast Carcinoma with Choriocarcinomatous Features


Prognostic Stage II Breast Cancer AJCC v8


Anatomic Stage IIA Breast Cancer AJCC v8


Malignant neoplasm of nipple of female breast


Paget's disease and infiltrating duct carcinoma of breast


Invasive Breast Lobular Carcinoma, Tubulolobular Variant


Hormone Receptor-Negative Breast Carcinoma


Breast Carcinoma with Osseous Metaplasia


Unresectable Hormone Receptor-Positive Breast Carcinoma


Invasive Breast Carcinoma of No Special Type with Predominant Intraductal Component


Prognostic Stage IA Breast Cancer AJCC v8


Pleomorphic lobular carcinoma in situ of breast


Invasive micropapillary carcinoma of breast


Anatomic Stage IIIB Breast Cancer AJCC v8


Paget's disease and intraductal carcinoma of breast


Invasive Breast Carcinoma by Histologic Grade


Recurrent HER2-Negative Breast Carcinoma


Recurrent Invasive Breast Carcinoma of No Special Type


Breast Ductal Carcinoma In Situ, Comedo Type


Prognostic Stage III Breast Cancer AJCC v8


solid type ductal carcinoma in situ of breast


Prognostic Stage IV Breast Cancer AJCC v8


Anatomic Stage IIIC Breast Cancer AJCC v8


Prognostic Stage IIIC Breast Cancer AJCC v8


Metastatic Triple-Negative Breast Inflammatory Carcinoma


Breast Tall Cell Carcinoma with Reversed Polarity


Anatomic Stage IIB Breast Cancer AJCC v8


Unresectable HER2-Positive Breast Carcinoma


Breast Ductal Carcinoma In Situ and Lobular Carcinoma


Breast Ductal Carcinoma In Situ, Non-Comedo Type


Locally Advanced Triple-Negative Breast Carcinoma


Invasive Breast Lobular Carcinoma, Signet Ring Variant


Prognostic Stage I Breast Cancer AJCC v8


Anatomic Stage IIIA Breast Cancer AJCC v8


Metastatic Breast Squamous Cell Carcinoma


adenocarcinoma of breast with spindle cell metaplasia


Ductal Carcinoma In Situ with Microinvasion


Unresectable Breast Inflammatory Carcinoma


Refractory HER2-Negative Breast Carcinoma


Breast Carcinoma with Chondroid Metaplasia


Early Stage Triple-Negative Breast Carcinoma


Breast Ductal Carcinoma with Squamous Metaplasia


Metastatic Hormone Receptor-Positive Breast Carcinoma


Invasive Breast Lobular Carcinoma, Pleomorphic Variant


Breast Carcinoma with Melanotic Features


Breast Paget Disease without Invasive Carcinoma


Breast Classic Lobular Carcinoma In Situ Type A


Unresectable Triple-Negative Breast Carcinoma


Inflammatory carcinoma of breast stage IV


Metastatic HER2-Positive Breast Carcinoma


Prognostic Stage IIIB Breast Cancer AJCC v8


Breast Ductal Carcinoma In Situ, Low Grade


Prognostic Stage IB Breast Cancer AJCC v8


Metastatic Squamous Cell Carcinoma in the Breast


Prognostic Stage IIA Breast Cancer AJCC v8


Breast Carcinoma Metastatic in the Brain


Encapsulated Breast Papillary Carcinoma with Invasion


Breast Carcinoma with Osteoclast-Like Stromal Giant Cells


Anatomic Stage III Breast Cancer AJCC v8


Low Grade Breast Mucoepidermoid Carcinoma


Metastatic BRCA-Associated Breast Carcinoma


Invasive Breast Lobular Carcinoma with Extracellular Mucin


Breast Ductal Carcinoma In Situ, Intermediate Grade


Recurrent Hormone Receptor-Positive Breast Carcinoma


adenocarcinoma of breast with squamous metaplasia


Recurrent Triple-Negative Breast Carcinoma


Locally Advanced HER2-Positive Breast Carcinoma


Breast Carcinoma Metastatic in the Central Nervous System


Locally Advanced Hormone Receptor-Positive Breast Carcinoma


pyramidal neuron migration to cerebral cortex


oligodendrocyte cell migration from the subpallium to the cortex


telencephalon oligodendrocyte cell migration


progressive transformation of germinal centers


Low Phospho-AKT Immunohistochemical Expression


Intestinal Metaplasia of Columnar Epithelium


Neoplastic Cells with CD45 Dim-to-Negative Expression Present


Lymphoblasts with Surface Immunoglobulin Present


Loss or Reduction of Nuclear Histone H3 K28me3 Expression


Renal Dysplasia Due to Fetal Exposure to ACE Inhibitor or ARB


Massive Sinusoidal Histiocytic Infiltrate


sinus histiocytosis with massive lymphadenopathy


Concentric Fibrosis of Intrahepatic Duct


Hurthle cell metaplasia of thyroid gland


Loss of Immunohistochemical Expression of Succinate Dehydrogenase (SDH) B


Microcalcification Present in Neoplastic and Non-Neoplastic Tissue


Microcalcification Present in Neoplastic Tissue


Intestinal Metaplasia of Esophageal Mucosa


Microcalcification Present in Non-Neoplastic Tissue


Neoplastic Cells with CD38 Dim-to-Negative Expression Present


High Phospho-AKT Immunohistochemical Expression


Minimal Reticulin Fibrosis of the Bone Marrow


Refractory Malignant Gastrointestinal Stromal Tumor


Refractory Extraskeletal Myxoid Chondrosarcoma


Refractory Undifferentiated Pleomorphic Sarcoma


Refractory Childhood Soft Tissue Sarcoma


Refractory Desmoplastic Small Round Cell Tumor


negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway


MAP kinase serine/threonine phosphatase activity


MAP kinase tyrosine phosphatase activity


Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7


Secondary Peripheral Atypical Cartilaginous Tumor


positive regulation of intestinal epithelial cell development


succinate-semialdehyde dehydrogenase (NAD+) activity


negative regulation of B cell chemotaxis


positive regulation of myeloid dendritic cell chemotaxis


negative regulation of myeloid dendritic cell chemotaxis


positive regulation of lymphocyte chemotaxis


regulation of myeloid dendritic cell chemotaxis


negative regulation of mast cell chemotaxis


negative regulation of dendritic cell chemotaxis


macular coloboma-cleft palate-hallux valgus syndrome


apoptotic process involved in salivary gland cavitation


posterior lateral line ganglion neuron differentiation


lateral line ganglion neuron differentiation


anterior lateral line ganglion neuron differentiation


negative regulation of calcium import into the mitochondrion


positive regulation of calcium ion transport into cytosol involved in cellular response to salt stress


positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion

biolink:Pathway biolink:OntologyClass biolink:BiologicalProcess biolink:Occurrent biolink:BiologicalProcessOrActivity biolink:BiologicalEntity biolink:NamedThing biolink:Entity biolink:PhysicalEssenceOrOccurrent


regulation of calcium ion import across plasma membrane


negative regulation of store-operated calcium entry


positive regulation of calcium ion import across plasma membrane


positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel


regulation of calcium import into the mitochondrion


positive regulation of calcium ion transport into cytosol involved in cellular response to calcium ion


negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel


regulation of calcium ion export across plasma membrane


negative regulation of calcium ion transport into cytosol involved in cellular response to salt stress


positive regulation of calcium import into the mitochondrion


negative regulation of calcium ion export across plasma membrane


positive regulation of calcium ion export across plasma membrane


positive regulation of store-operated calcium entry


negative regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion


positive regulation of calcium ion import into sarcoplasmic reticulum


negative regulation of calcium ion import across plasma membrane


positive regulation of fast-twitch skeletal muscle fiber contraction


regulation of fast-twitch skeletal muscle fiber contraction


negative regulation of fast-twitch skeletal muscle fiber contraction


beta-lactam antibiotic catabolic process


cytoplasm protein quality control by the ubiquitin-proteasome system


Secondary Peripheral Atypical Cartilaginous Tumor/Chondrosarcoma, Grade 1


Central Nervous System Mesenchymal Chondrosarcoma


Secondary Peripheral Chondrosarcoma, Grade 3


Unresectable Primary Central Chondrosarcoma


Locally Advanced Unresectable Primary Central Chondrosarcoma


Secondary Central Atypical Cartilaginous Tumor/Chondrosarcoma, Grade 1


Central Atypical Cartilaginous Tumor/Chondrosarcoma, Grade 1


Metastatic Primary Central Chondrosarcoma


Secondary Peripheral Chondrosarcoma, Grade 1


Secondary Peripheral Chondrosarcoma, Grade 2


Atypical Cartilaginous Tumor/Chondrosarcoma, Grade 1


Primary Central Atypical Cartilaginous Tumor/Chondrosarcoma, Grade 1


negative regulation of catalase activity


L-methionine salvage from methionine sulphoxide


protein insertion into ER membrane by N-terminal cleaved signal sequence


negative regulation of metanephric ureteric bud development


negative regulation of metanephric mesenchymal cell migration


mesonephric glomerular mesangium development


Stage IIA Lung Small Cell Carcinoma AJCC v7


Unresectable Thymic Neuroendocrine Neoplasm


Thymic Carcinoma, Not Otherwise Specified


Stage IIA Lung Squamous Cell Carcinoma AJCC v7


Stage IA Lung Small Cell Carcinoma AJCC v7


Stage I Pleural Malignant Mesothelioma AJCC v8


Stage IIIA Lung Squamous Cell Carcinoma AJCC v7


Locally Advanced Lung Non-Small Cell Carcinoma


Stage 0 Non-Small Cell Lung Cancer AJCC v6 and v7


Pleural Malignant Mesothelioma by AJCC v8 Stage


Mediastinal T Acute Lymphoblastic Leukemia


Metastatic Malignant Neoplasm in the Thoracic Cavity


Stage IIIB Pleural Malignant Mesothelioma AJCC v8


Mediastinal Germ Cell Tumor with Somatic-Type Malignancy


Invasive Lung Non-Mucinous Adenocarcinoma


Refractory Lung Non-Small Cell Squamous Carcinoma


Pleural mesothelioma malignant recurrent


Refractory Extensive Stage Lung Small Cell Carcinoma


Stage IIIB Thymic Epithelial Neoplasm AJCC v8


Cardiac Inflammatory Myofibroblastic Tumor


Stage III Pleural Malignant Mesothelioma AJCC v8


Stage 0 Squamous Cell Lung Carcinoma AJCC v6 and v7


Unresectable Lung Non-Small Cell Squamous Carcinoma


Thymic carcinoma with adenoid cystic carcinoma-like features


Platinum-Resistant Lung Small Cell Carcinoma


Lung Squamous Cell Carcinoma, Small Cell Variant


Lung Non-Keratinizing Squamous Cell Carcinoma


Stage IA Lung Squamous Cell Carcinoma AJCC v7


Pleural Well Differentiated Papillary Mesothelial Tumor


Stage IA Pleural Malignant Mesothelioma AJCC v8


Locally Advanced Lung Large Cell Neuroendocrine Carcinoma


Pleural Proximal-Type Epithelioid Sarcoma


Stage IIB Non-Small Cell Lung Carcinoma AJCC v7


Unresectable Lung Non-Small Cell Carcinoma


Resectable Lung Non-Small Cell Carcinoma


Malignant Mediastinal Germ Cell Tumor Stage Grouping of the Pediatric Study Group


Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7


Epithelioid hemangioendothelioma of lung


Stage IB Pleural Malignant Mesothelioma AJCC v7


Metastatic Lung Large Cell Neuroendocrine Carcinoma


Lung Non-Small Cell Cancer by AJCC v7 Stage


Stage III Malignant Mediastinal Germ Cell Tumor


Stage IIIA Pleural Malignant Mesothelioma AJCC v8


Unresectable Malignant Thoracic Neoplasm


Mediastinal T Lymphoblastic Leukemia/Lymphoma


Metastatic Thymic Neuroendocrine Neoplasm


Advanced Lung Non-Small Cell Squamous Carcinoma


Stage IIIA Lung Small Cell Carcinoma AJCC v7


Mediastinal Mixed Nongerminomatous Germ Cell Tumor


Stage 0 Lung Adenocarcinoma AJCC v6 and v7


Secondary malignant neoplasm of chest wall


Locally Advanced Lung Adenosquamous Carcinoma


Stage IB Lung Squamous Cell Carcinoma AJCC v7


Stage I Malignant Mediastinal Germ Cell Tumor


Advanced Lung Large Cell Neuroendocrine Carcinoma


Metastatic Pleural Malignant Mesothelioma


Stage IB Pleural Malignant Mesothelioma AJCC v8


Stage II Lung Small Cell Carcinoma AJCC v7


Stage IB Non-Small Cell Lung Carcinoma AJCC v7


Stage IB Lung Small Cell Carcinoma AJCC v7


Congenital Peribronchial Myofibroblastic Tumor


Micronodular thymoma with lymphoid stroma


Stage IV Pleural Malignant Mesothelioma AJCC v7


Stage I Thymic Epithelial Neoplasm AJCC v8


Stage IA Lung Non-Small Cell Carcinoma AJCC v7


Secondary malignant neoplasm of mediastinum


Thymic Epithelial Neoplasm by AJCC v8 Stage


Stage IV Malignant Mediastinal Germ Cell Tumor


Unresectable Pleural Malignant Mesothelioma


Stage IA Pleural Malignant Mesothelioma AJCC v7


malignant peripheral nerve sheath tumor (MPNST) of mediastinum


Lung Small Cell Carcinoma by AJCC v7 Stage


Stage II Pleural Malignant Mesothelioma AJCC v8


Advanced Lung Non-Squamous Non-Small Cell Carcinoma


Stage IVA Thymic Epithelial Neoplasm AJCC v8


Stage IIIA Thymic Epithelial Neoplasm AJCC v8


Stage III Thymic Epithelial Neoplasm AJCC v8


Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma


Recurrent Combined Thymic Epithelial Neoplasm


Stage III Lung Small Cell Carcinoma AJCC v7


Minimally Invasive Mucinous Lung Adenocarcinoma


Stage I Pleural Malignant Mesothelioma AJCC v7


Unresectable Lung Non-Squamous Non-Small Cell Carcinoma


Unresectable Lung Large Cell Neuroendocrine Carcinoma


Locally Advanced Lung Neuroendocrine Neoplasm


keratinizing squamous cell carcinoma of lung


Stage II Pleural Malignant Mesothelioma AJCC v7


Stage IIIB Lung Small Cell Carcinoma AJCC v7


Bronchiolar adenoma/ciliated muconodular papillary tumor


childhood mediastinal neurogenic neoplasm


Metastatic Lung Non-Squamous Non-Small Cell Carcinoma


Stage IV Lung Squamous Cell Carcinoma AJCC v7


Resectable Pleural Malignant Mesothelioma


Stage IIA Non-Small Cell Lung Carcinoma AJCC v7


malignant cardiac peripheral nerve sheath neoplasm


Lung Squamous Cell Carcinoma, Papillary Variant


Extramedullary Disease in Plasma Cell Myeloma Involving the Lung


Chest Wall Plexiform Fibrohistiocytic Tumor


Stage IIB Lung Small Cell Carcinoma AJCC v7


Stage II Thymic Epithelial Neoplasm AJCC v8


Platinum-Sensitive Lung Small Cell Carcinoma


Lung Squamous Cell Carcinoma by AJCC v7 Stage


Locally Advanced Pleural Malignant Mesothelioma


malignant melanocytic peripheral nerve sheath tumor of mediastinum


Basaloid squamous cell carcinoma of lung


Stage IV Thymic Epithelial Neoplasm AJCC v8


Stage II Malignant Mediastinal Germ Cell Tumor


Colorectal Carcinoma Metastatic in the Lung


Stage IIIB Lung Squamous Cell Carcinoma AJCC v7


Refractory Pleural Malignant Mesothelioma


Malignant Mediastinal Germ Cell Tumor with Associated Hematologic Malignancy


Refractory Lung Non-Small Cell Carcinoma


Unresectable Lung Neuroendocrine Neoplasm


Stage IIB Lung Squamous Cell Carcinoma AJCC v7


Prostate Carcinoma Metastatic in the Lung


Thymic Adenocarcinoma, Not Otherwise Specified


Pleural Malignant Mesothelioma by AJCC v7 Stage


Stage IV Pleural Malignant Mesothelioma AJCC v8


Stage I Lung Small Cell Carcinoma AJCC v7


Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7


Malignant Mediastinal Nongerminomatous Germ Cell Tumor


Pleural mesothelioma malignant localised


Malignant Intrathoracic Paravertebral Paraganglioma


Non-mucinous adenocarcinoma in situ of lung


Stage III Pleural Malignant Mesothelioma AJCC v7


Metastatic Lung Non-Small Cell Carcinoma


Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma


Metastatic Lung Non-Small Cell Squamous Carcinoma


Locally Advanced Lung Non-Small Cell Squamous Carcinoma


Lung Carcinoma Metastatic in the Central Nervous System


Stage IV Lung Small Cell Carcinoma AJCC v7


Refractory Lung Non-Squamous Non-Small Cell Carcinoma


Lung Mixed Squamous Cell and Glandular Papilloma


Lung Squamous Cell Carcinoma, Clear Cell Variant


autosomal recessive severe congenital neutropenia due to JAGN1 deficiency


primary immunodeficiency syndrome due to p14 deficiency


autosomal recessive severe congenital neutropenia due to CXCR2 deficiency


autosomal recessive severe congenital neutropenia


neutropenia, severe congenital, 8, autosomal dominant


neutropenia, severe congenital, 2, autosomal dominant


autosomal recessive severe congenital neutropenia due to CSF3R deficiency


neutropenia, lethal congenital, with eosinophilia


neutropenia, severe congenital, 1, autosomal dominant


autosomal recessive severe congenital neutropenia due to G6PC3 deficiency


autosomal dominant severe congenital neutropenia


neutropenia, severe congenital, 9, autosomal dominant


porokeratosis 8, disseminated superficial actinic type


porokeratosis 6, disseminated superficial actinic type


disseminated superficial actinic porokeratosis


porokeratosis 5, disseminated superficial actinic type


porokeratosis 4, disseminated superficial actinic type


porokeratosis 3, disseminated superficial actinic type


porokeratosis plantaris palmaris et disseminata


infiltrating nipple syringomatous adenoma


breasts and/or nipples, aplasia or hypoplasia of, 2


isolated congenital breast hypoplasia/aplasia


breast fibrocystic change, proliferative type


linear and whorled nevoid hypermelanosis


salivary gland type cancer of the breast


familial juvenile hypertrophy of the breast


craniofrontonasal dysplasia-Poland anomaly syndrome


breasts and/or nipples, aplasia or hypoplasia of, 1


non-proliferative fibrocystic change of the breast


Recurrent Cutaneous Melanoma of the Extremity


(+)-abscisic acid D-glucopyranosyl ester transmembrane transporter activity


alpha7-beta1 integrin-focal adhesion kinase complex

biolink:CellularComponent biolink:AnatomicalEntity biolink:ThingWithTaxon biolink:PhysicalEssence biolink:OrganismalEntity biolink:BiologicalEntity biolink:NamedThing biolink:Entity biolink:PhysicalEssenceOrOccurrent


N-terminal protein amino acid deamination


N-terminal peptidyl-amino acid deamination to pyruvic acid


N-terminal protein amino acid deamination, from amino carbon


N-terminal protein amino acid deamination, from side chain


Advanced Head and Neck Squamous Cell Carcinoma


Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck


Advanced Oral Cavity Squamous Cell Carcinoma


positive regulation of adaptive immune memory response


Locally Advanced Nasal Cavity Squamous Cell Carcinoma


Metastatic Nasal Cavity Squamous Cell Carcinoma


Unresectable Nasal Cavity Squamous Cell Carcinoma


keratinizing squamous cell carcinoma of nasal cavity


Palmoplantar keratoderma with leukoplakia


biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity


glutathione specific gamma-glutamylcyclotransferase activity


raffinose transmembrane transporter activity


spleen follicular dendritic cell network


Maternally Derived Graft Versus Host Disease


lactose catabolic process via tagatose-6-phosphate


lipopolysaccharide core region metabolic process


lactose catabolic process via UDP-galactose


trehalose metabolism in response to heat stress


trehalose biosynthesis in response to heat stress


sucrose catabolic process via 3'-ketosucrose


cellular oligosaccharide catabolic process


raffinose family oligosaccharide biosynthetic process


cellular oligosaccharide metabolic process


lipopolysaccharide core region biosynthetic process


sucrose catabolic process to fructose-6-phosphate through glucose and fructose


trehalose metabolism in response to cold stress


ajugose biosynthetic process using galactinol:raffinose galactosyltransferase


beta-L-Ara4N-lipid A biosynthetic process


ajugose biosynthetic process using galactan:galactan galactosyltransferase


trehalose metabolism in response to stress


trehalose metabolism in response to water deprivation


lactose catabolic process, using glucoside 3-dehydrogenase


trehalose catabolism in response to heat stress


sucrose catabolic process to fructose-6-phosphate and glucose-6-phosphate


SRP-dependent cotranslational protein targeting to membrane, docking


granulocyte macrophage colony-stimulating factor production


lysine biosynthetic process via diaminopimelate and N-succinyl-2-amino-6-ketopimelate


negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment


negative regulation of canonical Wnt signaling pathway involved in heart development


positive regulation of pheromone-dependent signal transduction involved in conjugation with cellular fusion


regulation of pheromone-dependent signal transduction involved in conjugation with cellular fusion


negative regulation of pheromone-dependent signal transduction involved in conjugation with cellular fusion


Peritoneum injury with open wound into cavity


'de novo' pyridoxal 5'-phosphate biosynthetic process


anaerobic cobalamin biosynthetic process


L-ascorbic acid biosynthetic process via GDP-alpha-D-mannose


thiamine diphosphate biosynthetic process


pyridoxal phosphate biosynthetic process from pyridoxamine


L-ascorbic acid biosynthetic process via UDP-alpha-D-glucuronate


thiamine-containing compound biosynthetic process


melibiose transmembrane transporter activity


acute monoblastic/monocytic leukemia in relapse


Refractory Acute Monoblastic and Monocytic Leukemia


Adult Acute Monoblastic and Monocytic Leukemia


Childhood Acute Monoblastic and Monocytic Leukemia


X-linked acrogigantism due to a point mutation


Periventricular Hemorrhage of the Newborn


Small for Gestational Age for Weight and Length


Small for Gestational Age with Failure of Catch-Up Growth


Transient Leukemoid Reaction of the Newborn


Intraventricular (nontraumatic) hemorrhage, grade 1, of fetus and newborn


Intraparenchymal Hemorrhage of the Newborn


negative regulation of stomach neuroendocrine cell differentiation


regulation of stomach neuroendocrine cell differentiation


mitochondrial complex 1 deficiency, nuclear type 14


negative regulation of angiotensin-activated signaling pathway


protein tyrosine phosphatase activity, metal-dependent


[3-methyl-2-oxobutanoate dehydrogenase (lipoamide)]-phosphatase activity


calcium-dependent phospholipase C activity


calmodulin-activated 3',5'-cyclic-GMP phosphodiesterase activity


phosphodiesterase activity, acting on 3'-phosphoglycolate-terminated DNA strands


sphingomyelin phosphodiesterase D activity


acid sphingomyelin phosphodiesterase activity


D,D-heptose 1,7-bisphosphate phosphatase activity


photoreceptor cyclic-nucleotide phosphodiesterase activity


mannosyl-inositol phosphorylceramide phospholipase activity


triphosphoric monoester hydrolase activity


deoxynucleoside triphosphate hydrolase activity


5-phospho-alpha-D-ribosyl 1,2-cyclic phosphate phosphodiesterase activity


mannosyl-diinositol phosphorylceramide phospholipase activity


inositol pentakisphosphate phosphatase activity


protein tyrosine phosphatase activity, via thiol-phosphate intermediate


[isocitrate dehydrogenase (NADP+)] phosphatase activity


phosphatidylglycerol phospholipase C activity


D-ribose 2,5-bisphosphate 2-phosphohydrolase activity


inositol phosphorylceramide phospholipase activity


diphosphoric monoester hydrolase activity


inositol phosphosphingolipid phospholipase activity


phosphatidylcholine phospholipase C activity


[hydroxymethylglutaryl-CoA reductase (NADPH)]-phosphatase activity


neutral sphingomyelin phosphodiesterase activity


inositol hexakisphosphate 2-phosphatase activity


3',5'-nucleotide bisphosphate phosphatase activity


GPI-mannose ethanolamine phosphate phosphodiesterase activity


5-phospho-alpha-D-ribose 1,2-cyclic phosphate 1-phosphohydrolase activity


7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity


glycosylphosphatidylinositol phospholipase D activity


L-threonine O-3-phosphate phosphatase activity


positive regulation of autophagic cell death


lncRNA-mediated post-transcriptional gene silencing


negative regulation of antibacterial peptide production


negative regulation of transforming growth factor beta2 activation


negative regulation of granzyme A production


negative regulation of tumor necrosis factor (ligand) superfamily member 11 production


negative regulation of macrophage inflammatory protein 1 alpha production


negative regulation of natural killer cell cytokine production


siRNA-independent facultative heterochromatin formation


negative regulation of chemokine (C-C motif) ligand 4 production


negative regulation of interleukin-19 production


negative regulation of interleukin-15 production


negative regulation of transforming growth factor beta3 production


negative regulation of macrophage inflammatory protein-1 gamma production


negative regulation of chemokine (C-C motif) ligand 6 production


negative regulation of chemokine (C-X-C motif) ligand 1 production


negative regulation of antifungal peptide production


negative regulation of transforming growth factor beta3 activation


suppression by virus of host type I interferon production


negative regulation of fractalkine production


negative regulation of T-helper 1 cell cytokine production


negative regulation of interleukin-21 production


negative regulation of interleukin-32 production


negative regulation of endothelin production


negative regulation of interleukin-26 production


siRNA-dependent pericentric heterochromatin formation


siRNA-mediated facultative heterochromatin formation


negative regulation of granulocyte colony-stimulating factor production


negative regulation of glial cell-derived neurotrophic factor production


negative regulation of B cell cytokine production


negative regulation of macrophage colony-stimulating factor production


negative regulation of antifungal peptide secretion


negative regulation of granzyme B production


negative regulation of type III interferon production


negative regulation of interleukin-25 production


inactivation of X chromosome by heterochromatin formation


negative regulation of interleukin-11 production


suppression by virus of host transcription initiation from RNA polymerase II promoter


negative regulation of antimicrobial peptide production


negative regulation of connective tissue growth factor production


negative regulation of interleukin-20 production


negative regulation of antibacterial peptide secretion


negative regulation of interleukin-7 production


suppression by virus of host transcription


suppression by virus of host gene expression


negative regulation of interleukin-34 production


negative regulation of interleukin-3 production


negative regulation of interleukin-24 production


negative regulation of chemokine (C-X-C motif) ligand 9 production


co-transcriptional gene silencing by RNA interference machinery


negative regulation of antimicrobial peptide secretion


negative regulation of transforming growth factor beta1 activation


negative regulation of interleukin-9 production


negative regulation of interleukin-27 production


silent mating-type cassette heterochromatin formation


negative regulation of interleukin-35 production


suppression by virus of host mRNA transcription via inhibition of RNA polymerase II activity


suppression by virus of host cytokine production


negative regulation of interleukin-17A production


negative regulation of interleukin-33 production


negative regulation of chemokine (C-C motif) ligand 1 production


negative regulation of interleukin-16 production


negative regulation of interleukin-37 production


RNAi-mediated antiviral immunity against RNA virus


negative regulation of chemokine (C-C motif) ligand 20 production


negative regulation of interleukin-1 alpha production


negative regulation of transforming growth factor beta activation


RNAi-mediated antiviral immunity against DNA virus


negative regulation of vascular endothelial growth factor production


negative regulation of interleukin-22 production


gene silencing by RNA-directed DNA methylation


negative regulation of myeloid dendritic cell cytokine production


Resectable Adenocarcinoma of Unknown Primary


anemia due to erythrocyte enzyme disorder


glycogen storage disease due to phosphoglycerate mutase deficiency


hemolytic anemia due to diphosphoglycerate mutase deficiency


Uridine monophosphate hydrolase deficiency


positive regulation of mitotic nuclear envelope disassembly


Intermediate (Locally Aggressive) Blood Vessel Neoplasm


Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma


Intermediate (Rarely Metastasizing) Blood Vessel Neoplasm


Transforming Growth Factor-Beta Overexpression


Fibroblast Growth Factor 1 Overexpression


Presence of ERBB2 Overexpressing Disseminated Tumor Cells


Fibroblast Growth Factor 2 Overexpression


hypertrophic or verrucous lupus erythematosus


nuclear membrane fusion involved in karyogamy


respiratory system lymphatic vessel smooth muscle


extracellular matrix organization in marginal zone involved in cerebral cortex radial glia guided migration


(Z,E)-alpha- farnesene synthase activity


Pancreatic Macrocystic Serous Cystadenoma


Von Hippel-Lindau Syndrome-Associated Pancreatic Serous Adenoma


Locally Advanced Gastrointestinal Stromal Tumor


Metastatic Gastrointestinal Stromal Tumor


mitochondrial complex 1 deficiency, nuclear type 16


smooth muscle tissue layer of ejaculatory duct


cellular response to N-acetyl-D-glucosamine


cellular response to chondroitin 6'-sulfate


metanephric glomerular endothelium development


mesonephric glomerular epithelium development


nystagmus 3, congenital, autosomal dominant


Chest Pain Along Right Upper Sternal Border


persistent polyclonal B-cell lymphocytosis


phosphatidylcholine biosynthesis from choline and CDP-diacylglycerol


response to very low fluence red light stimulus


response to low fluence red light stimulus


Unresectable Digestive System Mixed Adenoneuroendocrine Carcinoma


positive regulation of preblastoderm mitotic cell cycle


octamethylcyclotetrasiloxane catabolic process to dimethylsilanediol


anaerobic organosilicon metabolic process


protein localization to nuclear inner membrane


protein-glutamic acid ligase activity, elongating


protein-glutamic acid ligase activity, initiating


ribosomal protein S6 glutamate-glutamate ligase activity


ribosomal S6-glutamic acid ligase activity


Advanced Pancreatic Neuroendocrine Tumor


Pancreatic neuroendocrine tumor metastatic


Locally Advanced Pancreatic Neuroendocrine Tumor


spastic paraplegia, intellectual disability, nystagmus, and obesity;


deactivation of mitotic spindle assembly checkpoint


positive regulation of mitotic sister chromatid segregation


positive regulation of mitotic spindle elongation


negative regulation of mitotic spindle assembly checkpoint signaling


positive regulation of mitotic spindle elongation (spindle phase three)


negative regulation of chronic inflammatory response to antigenic stimulus


paraparetic variant of Guillain-Barre syndrome


Recurrent Prostate Acinar Adenocarcinoma


Adenocarcinoma of the prostate recurrent


Biochemically Recurrent Prostate Carcinoma


developmental and epileptic encephalopathy, 77


multiple congenital anomalies-hypotonia-seizures syndrome 3


multiple congenital anomalies-hypotonia-seizures syndrome 2


negative regulation of spore-bearing organ development


negative regulation of telium development


negative regulation of aecium development


negative regulation of sporocarp development involved in sexual reproduction


negative regulation of oogonium development


negative regulation of sporangium development


negative regulation of conidiophore development


negative regulation of oomycete sporangium development


negative regulation of cleistothecium development


negative regulation of basidium development


negative regulation of zygosporangium development


negative regulation of ascus development


negative regulation of sporangium germination


negative regulation of phialide development


negative regulation of uredinium development


transforming growth factor beta ligand-receptor complex


Phyllodes Tumor of Anogenital Mammary-Type Glands


positive regulation of shell calcification


negative regulation of enamel mineralization


negative regulation of shell calcification


positive regulation of enamel mineralization


paternal uniparental disomy of chromosome 7


Injury to stomach with open wound into cavity


Complex Endometrial Hyperplasia with Atypia


Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor


endonucleolytic cleaveage between SSU-rRNA and LSU-rRNA of tetracistronic rRNA transcript (SSU-rRNA, LSU-rRNA, 4.5S-rRNA, 5S-rRNA)


gallate catabolic process via gallate dioxygenase activity


gallate catabolic process via 2-pyrone-4,6-dicarboxylate


polydactyly of an index finger, unilateral


polydactyly of an index finger, bilateral


polydactyly of a biphalangeal thumb, unilateral


mesoaxial synostotic syndactyly with phalangeal reduction


polydactyly of a biphalangeal thumb, bilateral


familial avascular necrosis of femoral head


outer renal medulla peritubular capillary


Advanced Malignant Small Intestinal Neoplasm


Malignant neoplasm of small intestine, incl duodenum metastatic


Locally Advanced Small Intestinal Carcinoma


Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma


Small intestine adenocarcinoma metastatic


Advanced Small Intestinal Neuroendocrine Carcinoma


Locally Advanced Small Intestinal Adenocarcinoma


Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma


Metastatic Small Intestinal Neuroendocrine Carcinoma


muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A14


muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B14


autosomal recessive limb-girdle muscular dystrophy type 2T


ENSAT Stage III Adrenal Cortex Carcinoma


Open fracture of carpal bone, unspecified


trichorhinophalangeal syndrome, type III


trichorhinophalangeal syndrome type I or III


peptidoglycan-protein cross-linking via N6-mureinyl-L-lysine


peptidoglycan-protein cross-linking via L-threonyl-pentaglycyl-murein


peptidoglycan-protein cross-linking via L-alanyl-pentaglycyl-murein


protein-chondroitin sulfate linkage via chondroitin sulfate D-glucuronyl-D-galactosyl-D-galactosyl-D-xylosyl-L-serine


autosomal dominant nonsyndromic hearing loss 65


Asymptomatic COVID-19 Infection Laboratory-Confirmed


Symptomatic COVID-19 Infection Laboratory-Confirmed


Pancreatic Well Differentiated Ductal Adenocarcinoma


negative regulation of chemorepellent activity


positive regulation of chemorepellent activity


secretory dimeric IgA immunoglobulin complex


B-cell lymphoma, unclassifiable, with features intermediate between diffuse large b-cell lymphoma and classical Hodgkin lymphoma


negative regulation of TRAIL-activated apoptotic signaling pathway


L-methionine biosynthetic process from homoserine via O-succinyl-L-homoserine and cystathionine


poly(hydroxyalkanoate) biosynthetic process from glucose


Hermansky-Pudlak syndrome without pulmonary fibrosis


minimal pigment oculocutaneous albinism type 1


severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome


deaf blind hypopigmentation syndrome, Yemenite type


hypo- and hypermelanotic cutaneous macules-retarded growth-intellectual disability syndrome


terminal osseous dysplasia-pigmentary defects syndrome


nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome


dyschromatosis universalis hereditaria 1


linear hypopigmentation and craniofacial asymmetry with acral, ocular and brain anomalies


osteopathia striata-pigmentary dermopathy-white forelock syndrome


autosomal dominant oculocutaneous albinism


piebald trait-neurologic defects syndrome


temperature-sensitive oculocutaneous albinism type 1


oculocerebral hypopigmentation syndrome, Cross type


pigmentation defects-palmoplantar keratoderma-skin carcinoma syndrome


deafness, congenital, with total albinism


dyschromatosis universalis hereditaria 2


hyperpigmentation with or without hypopigmentation, familial progressive


leukonychia totalis-acanthosis-nigricans-like lesions-abnormal hair syndrome


dyschromatosis universalis hereditaria 3


familial progressive hyper- and hypopigmentation


microcephaly 9, primary, autosomal recessive


detection of molecule of oomycetes origin


adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation


adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate


adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate


positive regulation of ryanodine-sensitive calcium-release channel activity by adrenergic receptor signaling pathway involved in positive regulation of cardiac muscle contraction


Neoplastic Plasma Cells 30 Percent or More of Bone Marrow Nucleated Cells


Blasts Under 20,000 in Peripheral Blood White Cells


Blasts Under 25 Percent of Bone Marrow Nucleated Cells


Myeloblasts 1 Percent or Less of Peripheral Blood White Cells


Blasts 20-30 Percent of Bone Marrow Nucleated Cells


Blasts Expressing T-Lymphoid and Myeloid Markers Present


Blasts 30 Percent or More of Bone Marrow Nucleated Cells


Lymphoblasts More Than 50 Percent of Bone Marrow Nucleated Cells


Bone Marrow Dysplasia Present in Less than 10 Percent of Myeloid Cells


Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells


Blasts More than 10 Percent of Bone Marrow Nucleated Cells


Neoplastic Plasma Cells 20 Percent or More of Peripheral Blood White Cells


Myeloblasts 5 Percent or More of Peripheral Blood White Cells


Blasts 6-24 Percent of Bone Marrow Nucleated Cells


Myeloblasts 5-9 Percent of Bone Marrow Nucleated Cells


Monoblasts 80 Percent or More of Bone Marrow Monocytic Cells


Megakaryoblasts 50 Percent or More of Bone Marrow Nucleated Cells


Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells


Lymphoblasts 25 Percent or Less of Bone Marrow Nucleated Cells


Blasts 20 Percent or More of Bone Marrow Nucleated Cells


Blasts 5-9 Percent of Bone Marrow Nucleated Cells


Bone Marrow Dysplasia Present in 10 Percent or More of the Cells of Two or More Myeloid Cell Lines


Blasts Expressing CD56 and Immature T-Cell Markers Present


Blasts More than 60 Percent of Bone Marrow Nucleated Cells


Absolute Neutrophil Count Greater than or Equal to 500/mm3


Eosinophilia Greater than 1500 cells per Microliter


Blasts 20 Percent or Less of Bone Marrow Nucleated Cells


Lymphoblasts 1 Percent or More of Bone Marrow Nucleated Cells


Neoplastic Plasma Cells 10 Percent or More of Bone Marrow Nucleated Cells


Blasts 10-20 Percent of Bone Marrow Nucleated Cells


Blasts Under 30 Percent of Bone Marrow Nucleated Cells


Neoplastic Promonocytes in Bone Marrow Markedly Increased


Blasts Under 15 Percent of Peripheral Blood White Cells


Immature Granulocytes in Peripheral Blood Under 10 Percent


Myeloblasts Under 20 Percent of Peripheral Blood White Cells


Blasts More than 15 Percent of Bone Marrow Nucleated Cells


Bone Marrow Blasts Decreased by 50 Percent or More Compared to Pretreatment Level


Fetal Circulation with Increased Nucleated Erythrocytes


Blasts 1 Percent or More of Peripheral Blood White Cells


Blasts 5 Percent or More of Bone Marrow Nucleated Cells


Blasts Expressing B-Lymphoid, T-Lymphoid, and Myeloid Markers Present


Ring Sideroblasts Under 15 Percent of Erythroid Precursors


Blasts 10-19 Percent of Peripheral Blood White Cells


Immature Myeloid Cells Increased in Bone Marrow


Neoplastic Plasma Cells More than 50 Percent of Bone Marrow Nucleated Cells


Myeloblasts Under 1 Percent of Peripheral Blood White Cells


Neoplastic Plasma Cells More than 20 Percent of Bone Marrow Nucleated Cells


Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells


Blasts Less than 0.01 Percent of Bone Marrow Nucleated Cells


Neoplastic Plasma Cells 5 Percent or Less of Bone Marrow Nucleated Cells


Myeloblasts Under 10 Percent of Peripheral Blood White Cells


Blasts More than 10000 of Peripheral Blood White Cells


T-Cells Absent, T-Cell Receptor Signaling Defective and Natural Killer Cells and B-Cells Normal


Neoplastic Plasma Cells Under 5 Percent of Bone Marrow Nucleated Cells


Blasts 10-19 Percent of Bone Marrow Nucleated Cells


Blasts 5 Percent or More of Peripheral Blood White Cells


Blasts 50 Percent or More of Bone Marrow Nucleated Cells


Blasts 9 Percent or Less of Bone Marrow Nucleated Cells


Dual Population of Bone Marrow Blasts Present


Myeloblasts 90 Percent or More of Bone Marrow Non-Erythroid Cells


Myeloblasts 10 Percent or More of Bone Marrow Nucleated Cells


Blasts 0.01 Percent or More of Bone Marrow Nucleated Cells


Blasts Greater than or Equal to 5000 per mL


Mast Cells 20 Percent or More of Bone Marrow Nucleated Cells


Blasts More Than 5 Percent of Peripheral Blood White Cells


Monoblasts 20 Percent or More of Bone Marrow Nucleated Cells


Blasts 30 Percent or Less of Peripheral Blood White Cells


Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells


Blasts Under 20 Percent of Bone Marrow Nucleated Cells


Blasts 10 Percent or Less of Bone Marrow Nucleated Cells


Myeloblasts Under 2 Percent of Peripheral Blood White Cells


Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines


Blasts Under 5 Percent of Bone Marrow Nucleated Cells


Blasts Under 5 Percent of Peripheral Blood White Cells


T-Cells and Natural Killer Cells Absent B-Cells Normal


Immature Granulocytes in Peripheral Blood Increased


Blasts 6-25 Percent of Bone Marrow Nucleated Cells


Lymphoblasts 5 Percent or Less of Bone Marrow Nucleated Cells


Blasts 5-20 Percent of Bone Marrow Nucleated Cells


Lymphoblasts 20 Percent or More of Bone Marrow Nucleated Cells


Atypical Lymphocytes Present in Peripheral Blood


Blasts 0 Percent of Peripheral Blood White Cells


Hypereosinophilia of Undetermined Significance


Blasts 5-30 Percent of Bone Marrow Nucleated Cells


gp100:154-162-Reactive Peripheral Blood Lymphocytes Present


Neoplastic Plasma Cells Under 10 Percent of Bone Marrow Nucleated Cells


Blasts 5-25 Percent of Bone Marrow Nucleated Cells


Blasts 2-4 Percent of Peripheral Blood White Cells


Blasts 1 Percent of Peripheral Blood White Cells


Lymphoblasts 5-25 Percent of Bone Marrow Nucleated Cells


Myeloblasts 10-19 Percent of Bone Marrow Nucleated Cells


Myeloblasts More than 5 Percent of Bone Marrow Nucleated Cells


Blasts Under 30 Percent of Peripheral Blood White Cells


Mast Cells 10 Percent or More of Peripheral Blood White Cells


Neoplastic Plasma Cells Present in Bone Marrow


Neoplastic Plasma Cells 20 Percent or Less of Bone Marrow Nucleated Cells


Blasts 21-30 Percent of Bone Marrow Nucleated Cells


Lymphoblasts 5 Percent or More of Bone Marrow Nucleated Cells


Myeloblasts 5-19 Percent of Bone Marrow Nucleated Cells


CD5-Positive Blast Cells Greater than 50 Percent


Blasts More than 25 Percent of Bone Marrow Nucleated Cells


Neoplastic Plasma Cells 5 Percent or More of Peripheral Blood White Cells


Blasts 20,000 or Less of Peripheral Blood White Cells


Blasts More than 5 Percent of Bone Marrow Nucleated Cells


Blasts Under 10 Percent of Bone Marrow Nucleated Cells


Blasts Less Than 50 Percent of Bone Marrow Nucleated Cells


Prolymphocytes Exceed 55 Percent of Lymphoid Cells in the Peripheral Blood


Myeloblasts 5 Percent or More of Bone Marrow Nucleated Cells


Myeloblasts Under 5 Percent of Peripheral Blood White Cells


T-Cells and B-Cells Absent and Natural Killer Cells Normal


Blasts 15 Percent or Less of Bone Marrow Nucleated Cells


Lymphoblasts Less than 5 Percent of Bone Marrow Nucleated Cells


Blasts 2 Percent or More of Peripheral Blood White Cells


Blasts 6 Percent or More of Bone Marrow Nucleated Cells


Blasts Under 15 Percent of Bone Marrow Nucleated Cells


Blasts 50 Percent or Less of Bone Marrow Nucleated Cells


T-Cells, B-Cells and Natural Killer Cells Absent


Blasts 20 Percent or Less of Peripheral Blood White Cells


Neoplastic Plasma Cells 10-60 Percent of Bone Marrow Nucleated Cells


Neoplastic Plasma Cells Under 5 Percent of Peripheral Blood White Cells


Erythroid Precursors 80 Percent or More of Bone Marrow Nucleated Cells


Blasts 5 Percent or Less of Bone Marrow Nucleated Cells


Neoplastic Plasma Cells Between 20 and 50 Percent of Bone Marrow Nucleated Cells


Atypical Lymphocytes Present in Bone Marrow


Neoplastic Plasma Cells Under 50 Percent of Bone Marrow Nucleated Cells


Blasts 25 Percent or Less of Bone Marrow Nucleated Cells


Neoplastic Plasma Cells 60 Percent or More of Bone Marrow Nucleated Cells


Blasts More than 20 Percent of Bone Marrow Nucleated Cells


Blasts 60 Percent or More of Bone Marrow Nucleated Cells


Neoplastic Plasma Cells More than 30 Percent of Bone Marrow Nucleated Cells


Neoplastic Plasma Cells 10-59 Percent of Bone Marrow Nucleated Cells


Neoplastic Promyelocytes in Bone Marrow Markedly Increased


Myeloblasts 1 Percent of Peripheral Blood White Cells


Hemoglobinuria due to hemolysis from external causes


Neoplastic Plasma Cells Under 20 Percent of Bone Marrow Nucleated Cells


Blasts Expressing B-Lymphoid and T-Lymphoid Markers Present


Blasts 0.1 Percent or More of Bone Marrow Nucleated Cells


Blasts Expressing B-Lymphoid and Myeloid Markers Present


Myeloblasts 20 Percent or More of Bone Marrow Non-Erythroid Cells


Blasts 25 Percent or More of Bone Marrow Nucleated Cells


thrombocytopenia due to immune destruction


Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells


Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells


Blasts 5-19 Percent of Bone Marrow Nucleated Cells


Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells


Homozygous Hemoglobin C or E, Non-Disease


T-Cells Absent and Normal Natural Killer Cells and B-Cells


Neoplastic Plasma Cells Between 10 and 30 Percent of Bone Marrow Nucleated Cells


Erythroid Precursors 50 Percent or More of Bone Marrow Nucleated Cells


Ring Sideroblasts 15 Percent or More of Erythroid Precursors


Blasts 30,000 or Less of Peripheral Blood White Cells


Myeloblasts 5 Percent or Less of Bone Marrow Nucleated Cells


Blasts 11-20 Percent of Bone Marrow Nucleated Cells


Neoplastic Plasma Cells 30 Percent or Less of Bone Marrow Nucleated Cells


Lymphoma Cells More than 25 Percent of Bone Marrow Nucleated Cells


Blasts Under 20 Percent of Peripheral Blood White Cells


Bone Marrow Blasts Percentage Decreased by 5 to 25 Percent


Blasts 5 Percent or Less of Peripheral Blood White Cells


Blasts 30 Percent or Less of Bone Marrow Nucleated Cells


BCR-JAK2 Fusion in Hematologic Malignancies


Neoplastic Plasma Cells 10 Percent of Bone Marrow Nucleated Cells


Blasts 5-19 Percent of Peripheral Blood White Cells


Blasts 5-10 Percent of Bone Marrow Nucleated Cells


Lymphoblasts 5 Percent or More of Peripheral Blood White Cells


Blasts 10 Percent or More of Bone Marrow Nucleated Cells


Blasts 2 Percent or More of Bone Marrow Nucleated Cells


Blasts 1 Percent or More of Bone Marrow Nucleated Cells


Blasts Increased by Greater than or Equal to 50 Percent


Blasts Under 10 Percent of Peripheral Blood White Cells


Neoplastic Plasma Cells More than 5 Percent of Peripheral Blood White Cells


Blasts 6-19 Percent of Bone Marrow Nucleated Cells


fatty acyl-CoA reductase 1 dysregulation


positive regulation of microtubule minus-end binding


positive regulation of substance P receptor binding


positive regulation of cytokine activity


positive regulation of apolipoprotein binding


positive regulation of low-density lipoprotein particle receptor binding


positive regulation of actin filament binding


positive regulation of C-C chemokine binding


positive regulation of heparan sulfate proteoglycan binding


positive regulation of small GTPase binding


positive regulation of growth hormone activity


monoclonal mast cell activation syndrome


negative regulation of conidium formation


response to cytokinesis checkpoint signaling


Mixed phenotype acute leukemia T/myeloid


negative regulation of formin-nucleated actin cable assembly


Prostate Acinar Adenocarcinoma, Atrophic Variant


multiple epiphyseal dysplasia, with severe proximal femoral dysplasia


non-severe combined immunodeficiency due to polymerase delta deficiency


congenital corneal opacities, cornea guttata, and corectopia


chronic tubotympanic suppurative otitis media


active cochleovestibular Meniere disease


X-linked mixed hearing loss with perilymphatic gusher


malignant otitis externa caused by Pseudomonas aeruginosa


noradrenergic neuron fate commitment involved in brainstem development


peptide cross-linking via 2-(S-L-cysteinyl)-L-phenylalanine


hyperuricemic nephropathy, familial juvenile type 4


negative regulation of hematopoietic stem cell proliferation


negative regulation of mesenchymal stem cell proliferation


electrosensory lateral line system development


mechanosensory lateral line system development


anterior lateral line system development


positive regulation of calcium-mediated signaling involved in cellular response to calcium ion


Glomus Tumor of Uncertain Malignant Potential


telangiectasia, hereditary hemorrhagic, type 1


congenital stenosis of the inferior vena cava


congenital anomaly of the coronary sinus


CELSR1-related late-onset primary lymphedema


anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome


hereditary hemorrhagic telangiectasia type 3


congenital systemic arteriovenous fistula


discrete fixed membranous subaortic stenosis


aneurysm or dilatation of ascending aorta


congenital anomaly of superior vena cava


telangiectasia, hereditary hemorrhagic, type 5


multiple cutaneous and mucosal venous malformations


congenital alveolar dysplasia due to FGF10


EPHB4-related lymphatic-related hydrops fetalis


congenital anomaly of the great arteries


MPI-congenital disorder of glycosylation


hennekam lymphangiectasia-lymphedema syndrome 3


discrete fibromuscular subaortic stenosis


pulmonary valve agenesis-ventricular septal defect-persistent ductus arteriosus syndrome


pulmonary artery or pulmonary branch anomaly


lymphedema-atrial septal defects-facial changes syndrome


EPHB4-associated vascular malformation spectrum


capillary malformation-arteriovenous malformation 2


pulmonary atresia-intact ventricular septum syndrome


GJC2-related late-onset primary lymphedema


PIEZO1-related generalized lymphatic dysplasia with non-immune hydrops fetalis


macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome


right superior vena cava connecting to left-sided atrium


segmental outgrowth-lipomatosis-arteriovenous malformation-epidermal nevus syndrome


microcephaly with or without chorioretinopathy, lymphedema, or intellectual disability


Hennekam lymphangiectasia-lymphedema syndrome 1


persistent left superior vena cava connecting to the left-sided atrium


congenital pulmonary veins atresia or stenosis


congenital alveolar dysplasia due to TBX4


alveolar capillary dysplasia without misalignment of pulmonary veins


congenital pulmonary venous return anomaly


Hennekam lymphangiectasia-lymphedema syndrome 2


pulmonary valve agenesis-tetralogy of fallot-absence of ductus arteriosus syndrome


left superior vena cava persisting to left-sided atrium


famililal cerebral cavernous malformations


congenital anomaly of the inferior vena cava


azygos continuation of the inferior vena cava


hereditary hemorrhagic telangiectasia type 4


telangiectasia, hereditary hemorrhagic, type 2


right inferior vena cava connecting to left-sided atrium


congenital patent ductus arteriosus aneurysm


capillary malformation-arteriovenous malformation 1


positive regulation of interleukin-7 production


positive regulation of pole plasm oskar mRNA localization


Testicular Germ Cell Neoplasia In Situ with Extratubular Extension


23S rRNA (guanine(745)-N(1))-methyltransferase activity


L-alanine biosynthetic process via ornithine


L-alanine biosynthetic process from pyruvate


regulation of chemokine (C-X-C motif) ligand 9 production


positive regulation of chemokine (C-X-C motif) ligand 9 production


positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential


regulation of cardiac muscle cell membrane repolarization


negative regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization


negative regulation of membrane repolarization during atrial cardiac muscle cell action potential


positive regulation of membrane repolarization during cardiac muscle cell action potential


positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization


regulation of membrane repolarization during ventricular cardiac muscle cell action potential


negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential


positive regulation of membrane repolarization during atrial cardiac muscle cell action potential


regulation of membrane repolarization during cardiac muscle cell action potential


regulation of membrane repolarization during atrial cardiac muscle cell action potential


regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization


negative regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization


negative regulation of membrane repolarization during cardiac muscle cell action potential


Metastatic Rectal Squamous Cell Carcinoma


Locally Advanced Rectal Squamous Cell Carcinoma


peptidyl-D-alanine racemization via peptidyl-L-serine


positive regulation of inflammatory response to wounding


fourth ventricle choroid plexus epithelium


lateral ventricle choroid plexus epithelium


Lactiferous terminal ductal lobular unit


negative regulation of attachment of mitotic spindle microtubules to kinetochore


proximal convoluted tubule segment 1 cell differentiation


regulation of cellular component organization


negative regulation of vacuole fusion, non-autophagic


negative regulation of focal adhesion disassembly


positive regulation of mitotic cohesin dsDNA (leading strand) loading


regulation of beta-catenin-TCF complex assembly


negative regulation of beta-catenin-TCF complex assembly


regulation of actomyosin structure organization


positive regulation of postsynaptic density organization


negative regulation of telomerase catalytic core complex assembly


negative regulation of metaphase/anaphase transition of meiosis I


negative regulation of cardiac myofibril assembly


regulation of plasma membrane raft polarization


positive regulation of primary cell septum biogenesis


regulation of mating projection assembly


negative regulation of kinetochore assembly


activation of meiosis I spindle assembly checkpoint


positive regulation of phagosome maturation


calcium-dependent activation of synaptic vesicle fusion


positive regulation of Wnt-Frizzled-LRP5/6 complex assembly


regulation of mitotic actomyosin contractile ring assembly


positive regulation of assembly of large subunit precursor of preribosome


negative regulation of hyaluranon cable assembly


positive regulation of protein homotetramerization


negative regulation of basement membrane assembly involved in embryonic body morphogenesis


positive regulation of synaptic assembly at neuromuscular junction


regulation of maintenance of mitotic sister chromatid cohesion, centromeric


negative regulation of pseudohyphal septin ring assembly


regulation of maintenance of meiotic sister chromatid cohesion, arms


regulation of calcium-dependent activation of synaptic vesicle fusion


regulation of cytoskeleton polarization involved in growth plate cartilage chondrocyte division


positive regulation of collagen fibril organization


positive regulation of G protein-coupled receptor internalization


positive regulation of protein tetramerization


positive regulation of supramolecular fiber organization


negative regulation of neurofibrillary tangle assembly


negative regulation of tight junction disassembly


negative regulation of gap junction assembly


regulation of starch utilization system complex assembly


negative regulation of actin cytoskeleton reorganization


positive regulation of actin filament bundle convergence involved in mitotic contractile ring assembly


regulation of mitotic chromosome condensation


regulation of DNA recombinase mediator complex assembly


negative regulation of cellulosome assembly


negative regulation of excitatory synapse assembly


negative regulation of mitotic sister chromatid arm separation


positive regulation of plasma membrane bounded cell projection assembly


negative regulation of free ubiquitin chain polymerization


negative regulation of meiotic spindle elongation


positive regulation of formation of translation initiation ternary complex


negative regulation of blood microparticle formation


regulation of photoreceptor cell axon guidance


negative regulation of phagocytosis, engulfment


positive regulation of syncytium formation by virus


negative regulation of mitotic division septum assembly


regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly


regulation of Golgi vesicle fusion to target membrane


negative regulation of clathrin coat assembly


positive regulation of eukaryotic translation initiation factor 4F complex assembly


regulation of mitotic spindle elongation (spindle phase three)


regulation of pseudohyphal septin ring assembly


positive regulation of mitotic spindle organization


positive regulation of peroxisome organization


positive regulation of mitotic spindle disassembly


regulation of cardiac myofibril assembly


positive regulation of intermediate filament polymerization


positive regulation of presynapse assembly


regulation of excitatory synapse assembly


negative regulation of neuromuscular junction development


negative regulation of phospholipid translocation


positive regulation of high-density lipoprotein particle assembly


negative regulation of cell septum assembly


regulation of dorsal/ventral axon guidance


regulation of cytokinesis, actomyosin contractile ring assembly


positive regulation of plasma membrane repair


negative regulation of eukaryotic translation initiation factor 4F complex assembly


regulation of postsynaptic density assembly


regulation of cell-substrate junction organization


regulation of plasma membrane bounded cell projection organization


negative regulation of microvillus length


negative regulation of endoplasmic reticulum tubular network organization


positive regulation of secretory granule organization


positive regulation of mitotic cohesin unloading


negative regulation of chromosome condensation


positive regulation of starch utilization system complex assembly


negative regulation of mitotic spindle elongation (spindle phase three)


negative regulation of cytokinesis, actomyosin contractile ring assembly


negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly


negative regulation of secondary cell septum biogenesis


regulation of actin filament bundle convergence involved in mitotic contractile ring assembly


positive regulation of protein insertion into mitochondrial outer membrane


regulation of vacuole fusion, non-autophagic


positive regulation of postsynaptic density assembly


negative regulation of myosin II filament organization


regulation of mitotic cohesin dsDNA (leading strand) loading


regulation of mitotic cohesin ssDNA (lagging strand) loading


regulation of intermediate filament polymerization


negative regulation of microtubule nucleation


regulation of modification of synapse structure, modulating synaptic transmission


positive regulation of apoptosome assembly


regulation of actin cytoskeleton organization by cell-cell adhesion


positive regulation of actin filament annealing


negative regulation of chloroplast fission


negative regulation of dendritic cell dendrite assembly


negative regulation of vesicle fusion with Golgi apparatus


positive regulation of stress granule assembly


regulation of plasma membrane bounded cell projection assembly


negative regulation of integrin biosynthetic process


positive regulation of actin filament organization involved in mitotic actomyosin contractile ring assembly


negative regulation of phospholipid scramblase activity


positive regulation of gut granule assembly


regulation of mitotic nuclear envelope disassembly


regulation of metaphase/anaphase transition of meiosis II


positive regulation of phospholipid scramblase activity


positive regulation of fusion of virus membrane with host plasma membrane